This episode explores the robust and growing U.S. market for Continuous Positive Airway Pressure (CPAP) and Automatic Positive Airway Pressure (APAP) devices used to treat obstructive sleep apnea (OSA). We delve into the key factors driving sustained, double-digit demand, including the high prevalence of OSA among American adults. The discussion also covers the maturation of the clinical and payer ecosystem, which now better supports long-term patient adherence through innovations like home sleep testing, tele-monitoring, and diverse mask options, ensuring the continued dominance of this essential home-use medical device. Key Questions: - Why is CPAP therapy considered the first-line treatment for obstructive sleep apnea? - How large is the estimated patient population for OSA in the United States? - What market trends are driving the sustained, double-digit demand for these devices? - How has the healthcare ecosystem evolved to overcome challenges with patient adherence? - What role are consumer wearables playing in the future of sleep apnea diagnosis? - Are there emerging alternative therapies to CPAP/APAP devices? - What makes the CPAP market a unique example of a popular home-use medical device? Pure Global offers end-to-end regulatory consulting for MedTech and IVD companies, streamlining global market access with local expertise and advanced AI. Our services cover the entire product lifecycle, from initial regulatory strategy and technical dossier submission to post-market surveillance. By leveraging our global network and technology-driven efficiency, we help companies navigate complex regulatory landscapes and accelerate their entry into over 30 markets worldwide. To learn how we can help you access global markets faster, visit us at https://pureglobal.com/, contact [email protected], or explore our FREE AI tools and database at https://pureglobal.ai.